Cargando…
MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma
Cancer is the second leading cause of mortality after cardiovascular diseases in the United States. Chemotherapy is widely used to treat cancers. Since the development of drug resistance is a major contributor towards the failure of chemotherapeutic regimens, efforts have been made to develop novel...
Autores principales: | Gupta, Pranav, Li, Haichang, Zhang, Guan-Nan, Barbuti, Anna Maria, Yang, Yuqi, Lin, Pei-hui, Cai, Chuanxi, Tan, Tao, Ma, Jianjie, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461659/ https://www.ncbi.nlm.nih.gov/pubmed/36147477 http://dx.doi.org/10.7150/ijbs.67869 |
Ejemplares similares
-
MG53 Mitigates Nitrogen Mustard-Induced Skin Injury
por: Li, Haichang, et al.
Publicado: (2023) -
MG53 attenuates nitrogen mustard‐induced acute lung injury
por: Li, Haichang, et al.
Publicado: (2022) -
Cardiac effects and clinical applications of MG53
por: Zhong, Weina, et al.
Publicado: (2021) -
MG53 Does Not Manifest the Development of Diabetes in db/db Mice
por: Wang, Qiang, et al.
Publicado: (2020) -
MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling
por: Sermersheim, Matthew, et al.
Publicado: (2020)